Renal denervation offers a potentially transformative and minimally invasive option for treating hypertension. With this ...

Lehigh Valley Health Network’s Topper Cancer Institute has become the first in Pennsylvania to use histotripsy to treat ...

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.

Splenic abnormalities usually present as a focal lesion(s) or diffuse splenomegaly outside the context of trauma. Most ...

Boston Scientific looks to catch up with Medtronic and Recor Medical in the much-hyped renal denervation space with its ...

The move aims to broaden interventional cardiology therapies with ultrasound-based renal denervation therapy to treat ...

Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ...

Regular screening, adhering to nutritional guidelines, and avoiding risky behaviors are the effective ways to keep kidneys ...

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire SoniVie Ltd., ...

Boston Scientific (NYSE:BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment. As a ...

The office offers a full range of vascular ultrasound exams, including carotid artery screenings, abdominal aortic imaging, renal artery studies, and tests for deep vein thrombosis (DVT ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire SoniVie, a privately held medical device company that ...